Get started
ROCHE IROCHE IROCHE I

ROCHE I

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Bonds

1RO chart


Full chart

1RO upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪233.63 B‬ EUR
Dividend yield (indicated)
3.35%
Price to earnings Ratio (TTM)
28
Basic EPS (TTM)
12 EUR
Net income (FY)
‪8.80 B‬ EUR
Revenue (FY)
‪64.34 B‬ EUR
Shares float
‪29.01 M‬
Beta (1Y)
1.22

Employees


Employees (FY)
‪103.25 K‬
Change (1Y)
−356 −0.34%
Revenue / Employee (1Y)
‪623.19 K‬ EUR
Net income / Employee (1Y)
‪85.27 K‬ EUR

About ROCHE I


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Thomas Schinecker
Website
roche.com
Headquarters
Basel
Founded
1896
ISIN
CH0012032113
FIGI
BBG01TT1NNJ5
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1RO news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

1RO highest yielding bonds


CHGCY5317644
Roche Holdings, Inc. 2.607% 13-DEC-2051
Yield to maturity
7.19%
Maturity date
Dec 13, 2051
CHGCY4184535
Roche Holdings, Inc. 4.0% 28-NOV-2044
Yield to maturity
5.90%
Maturity date
Nov 28, 2044
CHGCY5766486
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.54%
Maturity date
Mar 8, 2054
CHGCY3666852
Genentech, Inc. 5.25% 15-JUL-2035
Yield to maturity
5.48%
Maturity date
Jul 15, 2035
CHGCY5766485
Roche Holdings, Inc. 5.218% 08-MAR-2054
Yield to maturity
5.36%
Maturity date
Mar 8, 2054
CHGCY5766483
Roche Holdings, Inc. 4.985% 08-MAR-2034
Yield to maturity
5.19%
Maturity date
Mar 8, 2034
CHGCY5698672
Roche Holdings, Inc. FRN 13-NOV-2026
Yield to maturity
5.18%
Maturity date
Nov 13, 2026
CHGCY5766481
Roche Holdings, Inc. 4.909% 08-MAR-2031
Yield to maturity
5.09%
Maturity date
Mar 8, 2031
CHGCY5317198
Roche Holdings, Inc. 2.076% 13-DEC-2031
Yield to maturity
4.98%
Maturity date
Dec 13, 2031
CHGCY5766479
Roche Holdings, Inc. 4.79% 08-MAR-2029
Yield to maturity
4.97%
Maturity date
Mar 8, 2029
CHGCY4391962
Roche Holdings, Inc. 7.0% 01-MAR-2039
Yield to maturity
4.93%
Maturity date
Mar 1, 2039

See all 1RO bonds 

Sparks


Curated watchlists where 1RO is featured.

See all sparks 


Check out other big names from the same industry as 1RO.

Frequently Asked Questions


The current price of 1RO is 306 EUR — it hasn't changed in the past 24 hours. Watch ROCHE I stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange ROCHE I stocks are traded under the ticker 1RO.
1RO stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in ROCHE I price.
We've gathered analysts' opinions on ROCHE I future price: according to them, 1RO price has a max estimate of 485.97 EUR and a min estimate of 235.49 EUR. Watch 1RO chart and read a more detailed ROCHE I stock forecast: see what analysts think of ROCHE I and suggest that you do with its stocks.
1RO stock is 0.00% volatile and has beta coefficient of 1.22. Track ROCHE I stock price on the chart and check out the list of the most volatile stocks — is ROCHE I there?
Yes, you can track ROCHE I financials in yearly and quarterly reports right on TradingView.
ROCHE I is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
1RO earnings for the last half-year are 9.12 EUR per share, whereas the estimation was 8.94 EUR, resulting in a 1.98% surprise. The estimated earnings for the next half-year are 11.22 EUR per share. See more details about ROCHE I earnings.
ROCHE I revenue for the last half-year amounts to ‪32.60 B‬ EUR, despite the estimated figure of ‪32.74 B‬ EUR. In the next half-year revenue is expected to reach ‪33.37 B‬ EUR.
1RO net income for the last half-year is ‪2.15 B‬ EUR, while the previous report showed ‪6.50 B‬ EUR of net income which accounts for −66.96% change. Track more ROCHE I financial stats to get the full picture.
Yes, 1RO dividends are paid annually. The last dividend per share was 10.17 EUR. As of today, Dividend Yield (TTM)% is 3.35%. Tracking ROCHE I dividends might help you take more informed decisions.
ROCHE I dividend yield was 3.58% in 2024, and payout ratio reached 93.40%. The year before the numbers were 3.67% and 66.71% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 7, 2025, the company has ‪103.25 K‬ employees. See our rating of the largest employees — is ROCHE I on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ROCHE I EBITDA is ‪22.37 B‬ EUR, and current EBITDA margin is 35.81%. See more stats in ROCHE I financial statements.
Like other stocks, 1RO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ROCHE I stock right from TradingView charts — choose your broker and connect to your account.